CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 190 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $744,000 | +148.0% | 106,172 | +193.0% | 0.11% | +180.0% |
Q1 2022 | $300,000 | +85.2% | 36,241 | +51.5% | 0.04% | +100.0% |
Q4 2021 | $162,000 | +18.2% | 23,928 | +0.3% | 0.02% | +33.3% |
Q2 2021 | $137,000 | -67.3% | 23,855 | -73.8% | 0.02% | -78.6% |
Q1 2021 | $419,000 | +24.7% | 90,890 | -9.7% | 0.07% | +27.3% |
Q4 2020 | $336,000 | +1.8% | 100,605 | +17.4% | 0.06% | -33.7% |
Q1 2020 | $330,000 | -53.1% | 85,680 | -54.3% | 0.08% | +1.2% |
Q4 2019 | $703,000 | +282.1% | 187,496 | +441.3% | 0.08% | +228.0% |
Q3 2019 | $184,000 | +82.2% | 34,638 | +32.1% | 0.02% | +127.3% |
Q2 2019 | $101,000 | -86.8% | 26,220 | -87.1% | 0.01% | -73.8% |
Q3 2018 | $767,000 | -35.4% | 202,845 | -46.7% | 0.04% | -28.8% |
Q2 2018 | $1,187,000 | +416.1% | 380,605 | +295.7% | 0.06% | +391.7% |
Q1 2018 | $230,000 | -81.0% | 96,196 | -79.9% | 0.01% | -85.4% |
Q3 2017 | $1,208,000 | +48.8% | 479,196 | -35.7% | 0.08% | +86.4% |
Q3 2016 | $812,000 | +84.5% | 745,077 | +20.2% | 0.04% | +83.3% |
Q2 2016 | $440,000 | – | 619,777 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |